Niemoller, Elisabeth,Silvestre, Louise,Boka, Gabor,Miossec, Patrick
申请号：
AU2012257850
公开号：
AU2012257850A1
申请日:
2012.05.11
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients. The combination comprises lixisenatide (AVEOOIO), a GLP-1 agonist and basal insulin.
